Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 27, 2026

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

Urologic applications of engineered tissue.

David M Kollhoff1, Earl Y Cheng, Arun K Sharma

  • 1Loyola University Medical Center, Maywood, IL 60153, USA.

Regenerative Medicine
|November 5, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selenium-Containing 1,4-Naphthoquinone Derivatives Trigger Reactive Oxygen Species and Apoptosis in Triple-Negative Breast Cancer Cells.

Drug development research·2026
Same author

Handheld hyperspectral imaging dataset of annual sowthistle and little mallow under abiotic stress for machine learning.

Data in brief·2026
Same author

Microbial dysbiosis in metabolic disorders: linking epigenomic regulation and pathological mechanisms.

Drug discovery today·2026
Same author

Targeting bacitracin resistance-associated histidine kinase (BraS) in MRSA with isatin and indazole derivatives.

Scientific reports·2026
Same author

Laryngeal leishmaniasis presenting with hoarseness in a child from the highland of Nepal: A rare diagnostic challenge.

IDCases·2026
Same author

CerS2 Is a Druggable Target in Triple-Negative Breast Cancer.

Molecular cancer therapeutics·2026

Tissue engineering offers promising solutions for genitourinary tract reconstruction, aiming to improve functional restoration and reduce complications. This approach utilizes engineered tissues to better repair congenital and acquired anomalies.

Area of Science:

  • Urology
  • Regenerative Medicine
  • Biomaterials Science

Background:

  • Genitourinary tract anomalies often require surgical repair using grafts (skin, oral mucosa, bowel).
  • Current grafting methods restore anatomy but frequently fail to fully restore function.
  • Postoperative complications are common, particularly with bowel augmentation or neobladder creation.

Purpose of the Study:

  • To explore the potential of tissue engineering as an alternative to traditional grafting methods in urology.
  • To discuss the selection of scaffolding materials and cell sources for engineered urological tissues.
  • To review current applications and future prospects of tissue engineering in urological reconstruction.

Main Methods:

  • Focus on the selection criteria for scaffolding materials.

More Related Videos

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair
09:43

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

Published on: February 24, 2016

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

Related Experiment Videos

Last Updated: May 27, 2026

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair
09:43

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

Published on: February 24, 2016

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

  • Analysis of various autologous cell sources (bladder cells, stem cells, adipose tissue).
  • Review of existing literature on tissue engineering applications in urology.

    • Main Results:

    • Engineered tissues hold the potential to restore or preserve normal organ function.
    • Autologous engineered tissues are expected to be non-immunogenic, minimizing rejection.
    • Tissue engineering offers a promising avenue to mitigate limitations of current reconstructive techniques.

    Conclusions:

    • Tissue engineering presents a viable strategy to overcome the functional deficits and complications associated with current urological reconstructive procedures.
    • Further research into scaffolding and cell sourcing is crucial for successful clinical translation.
    • The development of functional, non-immunogenic engineered tissues could revolutionize urological surgery.